Stocks and Investing
Stocks and Investing
Fri, March 6, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, March 5, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
David Westenberg Initiated (TXG) at Strong Buy on, Mar 5th, 2020
David Westenberg of Guggenheim, Initiated "10x Genomics, Inc." (TXG) at Strong Buy on, Mar 5th, 2020.
David has made no other calls on TXG in the last 4 months.
There are 2 other peers that have a rating on TXG. Out of the 2 peers that are also analyzing TXG, 0 agree with David's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with David
- Patrick Donnelly of "Citigroup" Initiated at Strong Buy and Held Target at $100 on, Tuesday, January 7th, 2020
- Tycho Peterson of "JP Morgan" Maintained at Buy with Increased Target to $65 on, Friday, November 8th, 2019